What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement
Banner Ad Advertisement
Charles River

Rapid ATP-Bioluminescence for Non-sterile Product Testing: Roadmap to Implementation

Visit Website
Rapid ATP-Bioluminescence for Non-sterile Product Testing: Roadmap to Implementation


Webinar Overview

Despite the clear advantages rapid microbiological methods (RMMs) provide over traditional ones, the pharmaceutical industry’s acceptance of them has been slow due in part to challenges encountered during validation coupled with a lack of global regulatory acceptance. These obstacles, along with potential bottlenecks and differences in regional health authority requirements, are valid concerns that need to be carefully assessed when considering an RMM.


It can be done, though. In this webinar we discuss the global implementation of the Celsis® ATP-bioluminescence system for non-sterile material testing using the validation approach according to USP <1223>, Ph. Eur. 5.1.6, and PDA TR33. Inge Van der Schoot, Senior Scientist at Janssen, presents information for decision-makers and technical scientific personnel seeking to learn more about:


WEBINAR PRESENTER

2021-05-06_15-34-26.png

Inge Van der Schoot

Senior Scientist

Janssen, Pharmaceutical Companies of Johnson & Johnson


We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.

TODAY'S POSTS
SUBSCRIBE
Charles River

Charles River News & Announcements

In today’s world, quality and compliance are non-negotiable, and yesterday’s standards are no longer sufficient to meet the demands of a constantly evolving landscape. The field of quality control microbiology is undergoing a disruptive revolution to safeguard patient safety, evolving beyond traditional methods to optimize resources, minimize human error, enable sustainable alternatives, and maintain consistent quality standards. Every test, every result, and every data point define the success of life-changing therapies. That’s why we’re leading a new paradigm, one that redefines efficiency, sustainability, and innovation. Let’s rethink the future of microbial quality control, where modern, automated, data-centric, and scalable solutions are the norm, empowering you to stay ahead in a dynamic regulatory and operational landscape.  Together, we are not just preparing for the future. We’re rethinking it. Because every moment matters.

PROFILE
WEBSITE
10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

PROFILE
LINKEDIN
WEBSITE

This post is related to:

TODAY'S POSTS

Connect with RXinsider

Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.

Subscribe
Advertise

RXinsider
1300 Division Road, Suite 103
West Warwick, RI 02893

The BUZZ / News

Publications

Marketplace

Multimedia Content

Market Intelligence

Career Center

Subscribe

Company

Subscribe
© 2025 RXinsider | All Rights Reserved.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Rapid ATP-Bioluminescence for Non-sterile Product Testing: Roadmap to Implementation

Name
Address
Subscribe